Vallon Pharmaceuticals Inc. (VLON:NASDAQ) soared at $0.6, representing a gain of 54.6%. On Mon, Mar 06, 2023, VLON:NASDAQ hit a New 2-Week Intraday Low of $0.37. The stock got featured on our News Catalysts scanner on Fri, Feb 24, 2023 at 07:47 AM in the 'EARNINGS' category. From Tue, Feb 21, 2023, the stock recorded 22.22% Up Days and 20.00% Green Days
The stock spiked on Mon, Feb 13, 2023 at $1.23 with a volume of 177M+.
About Vallon Pharmaceuticals Inc. (VLON:NASDAQ)
Vallon Pharmaceuticals Inc is a biopharmaceutical company primarily focused on the development and commercialization of proprietary biopharmaceutical products.
Top 10 Gainers:
- Appreciate Holdings Inc Cl A (SFR:NASDAQ), 159.32%
- Unicycive Therapeutics Inc. (UNCY:NASDAQ), 153.06%
- Ambrx Biopharma Inc. American Depositary Shares (each representing seven) (AMAM:NYSE), 95.02%
- Bellerophon Therapeutics, Inc. (BLPH:NASDAQ), 92.86%
- Genelux Corporation (GNLX:NASDAQ), 60.42%
- Orchestra BioMed Holdings Inc Com (OBIO:NASDAQ), 58.09%
- Vallon Pharmaceuticals Inc. (VLON:NASDAQ), 54.64%
- Avalon GloboCare Corp. (ALBT:NASDAQ), 53.92%
- BridgeBio Pharma, Inc. (BBIO:NASDAQ), 51.98%
- Troika Media Group Inc. (TRKA:NASDAQ), 48.64%